Patient Support Services Contact Us
Image: Coherus Investors

Snapshot

Revenue & Earnings

Revenue (FY) $475.82
EBIT (Mil) (FY) $156.32
EBIT (Mil) (MRQ) $-167.36
EBIT (Mil) (TTM) $-51.91
EBITDA (Mil) (FY) $159.22
EBITDA (Mil) (MRQ) $-166.51
EBITDA (Mil) (TTM) $-48.71
Net Income Excluding Extraordinary Items (Mil) (FY) $132.24
Net Income Including Extraordinary Items (Mil) (FY) $132.24
Diluted EPS Excluding Extraordinary Items (FY) $1.62
Diluted EPS Including Extraordinary Items (FY) $1.62

Dividends

Yield (%) --
Dividend Record Date
Dividend Rate --%

Ratios

Price to Revenue (TTM) $2.42
Price to Revenue (MRQ) $3.22
Price to Revenue (FY) $2.25
Price To Cash Flow (TTM) --
Price to Cash Flow (MRQ) --
Price to Cash Flow (FY) $7.93
Price to Book (MRQ) $8.10
Price to Book (FY) $3.65
Total Debt to Equity (MRQ) (%) 318.42%
Total Debt to Equity (FY) (%) 144.30%
Current Ratio (MRQ) $2.40
Current Ratio (FY) $5.27

Growth

5-Year Annual Dividend Growth Rate (%) --%
5-Year Annual Revenue Growth Rate (%) 73.76%

FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months.

Copyright Refinitiv